We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RP
501
DELISTED
RealPage, Inc.
RP
| $23M | 0.03% |
378,803
-338,892
| -47% | -$19.4M |
|
502
Caesars Entertainment
CZR
$6.1B
| $22.9M | 0.03% |
490,544
+478,864
| +4,100% | +$21.8M |
|
503
Agios Pharmaceuticals
AGIO
$2.14B
| $22.3M | 0.03% |
330,652
+36,460
| +12% | +$2.12M |
|
504
Edwards Lifesciences
EW
$48.6B
| $22.3M | 0.03% |
349,581
-21,966
| -6% | -$1.25M |
|
|
WRK
505
DELISTED
WestRock Company
WRK
| $22.3M | 0.03% |
581,375
-21,497
| -4% | -$841K |
|
506
Blackstone
BX
$150B
| $22.2M | 0.03% |
634,900
-30,000
| -5% | -$1M |
|
507
Albemarle
ALB
$13.9B
| $22.1M | 0.03% |
269,581
-16,079
| -6% | -$1.31M |
|
508
Plains All American Pipeline
PAA
$17.3B
| $22.1M | 0.03% |
901,254
+8,578
| +1% | +$203K |
|
509
Avery Dennison
AVY
$12.1B
| $21.9M | 0.03% |
194,204
+48,865
| +34% | +$5.05M |
|
510
Haemonetics
HAE
$3.55B
| $21.9M | 0.03% |
250,445
-30,877
| -11% | -$2.81M |
|
511
GSK
GSK
$102B
| $21.8M | 0.03% |
417,512
+23,578
| +6% | +$1.18M |
|
512
Bankunited
BKU
$3.34B
| $21.8M | 0.03% |
651,935
+14,956
| +2% | +$515K |
|
513
Fidelity National Information Services
FIS
$21B
| $21.7M | 0.03% |
191,748
-42,869
| -18% | -$4.57M |
|
514
Expeditors International
EXPD
$23.2B
| $21.7M | 0.03% |
285,494
+19,149
| +7% | +$1.38M |
|
515
WEX
WEX
$5.4B
| $21.6M | 0.03% |
112,601
-7,991
| -7% | -$1.35M |
|
516
Booz Allen Hamilton
BAH
$7.93B
| $21.6M | 0.03% |
371,105
+9,452
| +3% | +$491K |
|
|
DOOR
517
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $21.6M | 0.03% |
432,110
+10,667
| +3% | +$568K |
|
|
AJRD
518
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $21.5M | 0.03% |
605,206
+65,126
| +12% | +$2.4M |
|
519
Simon Property Group
SPG
$73.4B
| $21.5M | 0.03% |
117,768
+35,308
| +43% | +$6.28M |
|
520
Public Storage
PSA
$54.7B
| $21.3M | 0.03% |
97,929
+25,311
| +35% | +$5.3M |
|
|
AYX
521
DELISTED
Alteryx Inc
AYX
| $21.3M | 0.03% |
+253,710
| New | +$18.3M |
|
522
Diamondrock Hospitality Co
DRH
$2.64B
| $21.2M | 0.03% |
1,956,675
-1,090,788
| -36% | -$11.3M |
|
523
BCE
BCE
$20B
| $21.2M | 0.03% |
477,180
-65,195
| -12% | -$2.81M |
|
524
TransDigm Group
TDG
$66.8B
| $21.1M | 0.03% |
46,493
+43,749
| +1,594% | +$17.8M |
|
|
HMHC
525
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $21M | 0.03% |
2,894,872
+739,343
| +34% | +$6.64M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.